Vivo Capital, LLC Verona Pharma PLC Call Options Transaction History
Vivo Capital, LLC
- $748 Million
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VRNA
# of Institutions
115Shares Held
60.7MCall Options Held
139KPut Options Held
67.8K-
Nea Management Company, LLC Timonium, MD5.11MShares$79 Million5.77% of portfolio
-
Wellington Management Group LLP Boston, MA3.91MShares$60.4 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY3.76MShares$58.2 Million1.27% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.4MShares$52.5 Million1.23% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.19MShares$49.3 Million1.69% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $942M
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...